CrossrefInfokarte
Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)
Open Access Journal of Clinical Trials · 2018
DOI: 10.2147/oajct.s155706 ↗Abstract
Kein Abstract verfügbar.
EUVIMED